R
Arcus Biosciences, Inc.
RCUS · NYSE · Healthcare · 3.7B
Price · close
$30.34
+2.78% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.2×
Enterprise value / EBITDAEV/EBITDA
-9.4×
Free cash flow yieldFCF yield
-14.9%
Return on equityROE
-55.9%
Operating margin
-156.3%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-48.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.